BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 7638523)

  • 1. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
    Gerretsen M; Visser GW; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Cancer Res; 1993 Aug; 53(15):3524-9. PubMed ID: 8339258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How far have we come with solid (nonhematologic) tumor radioimmunotherapy?
    Breitz HB
    J Nucl Med; 2000 Dec; 41(12):2011-4. PubMed ID: 11138686
    [No Abstract]   [Full Text] [Related]  

  • 3. Is there a role for lymphoscintigraphy and sentinel node biopsy in the management of the regional lymphatics in mucosal squamous cell carcinoma of the head and neck?
    Hyde N; Prvulovich E
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):579-84. PubMed ID: 11976794
    [No Abstract]   [Full Text] [Related]  

  • 4. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
    Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies for diagnosis and therapy of squamous cell carcinoma of the head and neck.
    Gripp FM; Quak J; Leverstein H; Schrijvers A; Gerretsen M; Brakenhoff R; Van Dongen G; Snow GB; Rapoport A
    Sao Paulo Med J; 1994; 112(3):612-21. PubMed ID: 7638523
    [No Abstract]   [Full Text] [Related]  

  • 6. Current perspectives in the use of monoclonal antibodies for detection and treatment of head and neck tumors.
    Quak J; van Dongen G
    Eur Arch Otorhinolaryngol; 1994; 251(1):1-5. PubMed ID: 8179860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary.
    Jereczek-Fossa BA; Jassem J; Orecchia R
    Cancer Treat Rev; 2004 Apr; 30(2):153-64. PubMed ID: 15023433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunodetection and radioimmunotherapy of head and neck cancer.
    Börjesson PK; Postema EJ; de Bree R; Roos JC; Leemans CR; Kairemo KJ; van Dongen GA
    Oral Oncol; 2004 Sep; 40(8):761-72. PubMed ID: 15288829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel node localization in head and neck tumors.
    Pitman KT
    Semin Nucl Med; 2005 Oct; 35(4):253-6. PubMed ID: 16150245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia in head and neck cancer: studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins.
    Rischin D; Fisher R; Peters L; Corry J; Hicks R
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S61-3. PubMed ID: 17848298
    [No Abstract]   [Full Text] [Related]  

  • 11. [Radiation therapy for head and neck cancer].
    Mitsuhashi N; Akimoto T; Hayakawa K; Muramatsu H; Niibe H
    Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jan; 61(1):10-6. PubMed ID: 11218740
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.